| Dear Voornaam
Join us on 20 June from 1-2 PM for the first webinar in our new series supporting data-enabled cancer research.
In this first session, Research Data 101, youll hear from our internal data experts on simple approaches to make sure data is findable, accessible, interoperable and reusable. Theyll also cover how were supporting researchers to maximise the impact of data and deliver the best possible patient outcomes. Attendees will have the chance to ask the panel about our research data strategy and what were doing to unleash the potential of cancer data. |
|
|---|
|
|---|
|
|
Funding & Research Opportunities |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
PROFESSOR JEFFREY WILLIAM POLLARD Were deeply saddened by Jeffrey Pollards death on 1 May. An esteemed scientist and a wonderful mentor, Jeff pioneered research in reproductive biology and the tumour microenvironment.
Jeff had longstanding links to Cancer Research UK, he carried out his PhD at ICRF and held several CRUK programme grants. In recent years, his research focused on the mechanisms of action of female sex steroid hormones in controlling cell proliferation and on the tumour microenvironment of breast cancer. He was the first to demonstrate the protumoural role of macrophages in cancer. |
|
|---|
|
|---|
|
|
THE LATEST ON AI & COMPUTATIONAL MODELLING IN RADIATION RESEARCH Are you interested in the use of computational modelling and data science approaches in radiation therapy?
Hear from Ceilidh Welsh (University of Cambridge) who will chair a session at our Radiation Research Conference and explore examples of executable biology, radiomics and models of patient heterogeneity.
Our international event taking place in Glasgow on 46 June is for anyone involved in radiation research and related disciplines |
|
|---|
| REGISTER FOR OUR VIRTUAL SESSION ON RISK AND EARLY DIAGNOSIS Join us on 31 May for our spring virtual session on implementing risk in the diagnosis of cancer. Chaired by Jon Emery (University of Melbourne), the event will showcase some of the latest research into risk and its potential to support earlier cancer diagnosis.
Our expert panel will discuss their research into the optimisation of current pathways using risk prediction and risk stratification, and the barriers and enablers to implementing risk innovation into policy and practice. |
|
|---|
|
|---|
|
|
A PARTNERSHIP TO ACCELERATE GLOBAL PROGRESS AGAINST CANCER Weve joined G7 Cancer, an initiative set up by the French National Cancer Institute to unite the leading global cancer organisations, strengthen international cooperation and encourage the sharing of knowledge and expertise.
This week, we attended G7s first meeting in Paris, with representatives signing a memorandum of understanding which set the cooperation framework and defined the priority actions as setting up: an international conference on data strategy for paediatric cancers an international dialogue on pancreatic, liver, oesophagus, and stomach cancers a working group on cancer outcome inequities a working group on prevention and precancer |
|
|---|
|
|---|
|
|
NEW CORE FUNDING FOR HEALTH DATA RESEARCH UK Were joining nine other UK government and charity funders to fund Health Data Research UK's vital work in transforming the potential of UK health data.
Over the next five years, this funding will enable Health Data Research UK to increase the speed, scale and quality of health data science through new UK-wide research programmes. |
|
|---|
| ACCELERATE YOUR EARLY-STAGE DATA-FOCUSED STARTUP TO FURTHER INNOVATIONS TACKLING CANCER Cancer Research Horizons is sponsoring one promising start-up focused on cancer as part of KQ Labs accelerator programme. Run by the Francis Crick Institute, KQ Labs will provide data-driven, health start-ups a customised framework with cohort-specific mentoring workshops covering a breadth of topics including fundraising, pitch training, business models and market access.
By joining the programme, you will receive 40k funding in the form of a convertible loan, specialised investor introductions, one-on-one mentoring from subject-matter experts and access to the Cancer Research UK network and expertise. |
|
|---|
|
|---|
|
|
| Explore our research data strategy |
|---|
| |
|---|
|
|
| | | Online 10:00 AM 31 May 2023 |
|
|---|
|
|---|
| | | Cambridge, UK 05 July 2023 |
|
|---|
|
|---|
| | | Online 4:00 PM 05 July 2023 |
|
|---|
|
|---|
| | | Online 4:00 PM 27 September 2023 |
|
|---|
|
|---|
| | | Berlin, Germany 10 October 2023 |
|
|---|
|
|---|
| | | London, UK 10 October 2023 |
|
|---|
|
|---|
| | | London, UK 14 November 2023 |
|
|---|
|
|---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
|---|
|
|---|
|
|
| Been forwarded this email?
Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
